OLUTASIDENIB | N215814 | RIGEL PHARMACEUTICALS INC
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9834539 | Sep 18, 2035 | — | Yes | Yes | — | |
| 10414752 | Sep 18, 2035 | — | — | Yes | — | — |
| 10532047 | May 16, 2039 | — | Yes | — | — | — |
| 10550098 | Sep 18, 2035 | — | — | Yes | — | — |
| 10959994 | May 16, 2039 | — | — | Yes | — | — |
| 11013733 | May 16, 2039 | — | — | — | — | |
| 11013734 | May 16, 2039 | — | — | — | — | |
| 11376246 | May 16, 2039 | — | — | — | — | |
| 11497743 | May 16, 2039 | — | — | — | — | |
| 11498913 | Sep 18, 2035 | — | — | Yes | — | — |
| 11723905 | Nov 12, 2039 | — | — | Yes | — | — |
| 11738018 | Jul 17, 2039 | — | — | — | — | |
| 12053463 | May 16, 2039 | — | Yes | Yes | — | — |
| 12275715 | Sep 18, 2035 | — | Yes | Yes | — |
| Code | Date | Status |
|---|---|---|
| NCE | Dec 1, 2027 | Active |
| ODE-413 | Dec 1, 2029 | Active |